Investing in 2022 vs. 2023: How Chicago Capital LLCs Q4 2022 vs. Q1 2023 Holdings Compare

The world of investing is always changing, and staying on top of the latest market trends can be a challenging task. That’s why analyzing the quarterly holdings report for Chicago Capital LLC, one of the leading investment firms in the country, is critical for investors looking to make smart decisions. In this article, we will compare the Q4 2022 vs. Q1 2023 holdings for 50 investments in the Chicago Capital LLC portfolio and examine what changes occurred over the past two quarters.

Chicago Capital LLC's Top Gainers

VISA Inc (V) saw an increase in shares held by the company from 364,878 in Q4 2022 to 366,533 in Q1 2023, indicating a 9% increase in shareholding value. Apple Inc (AAPL), one of the most valuable companies in the world, also saw an increase in shares, with the company's holdings going from 466,763 in Q4 2022 to 467,139 in Q1 2023, resulting in a 27% increase in the value of Chicago Capital LLC's shares.

Fair Isaac Corp (FICO) saw slight growth in value, with shares decreasing slightly from 109,034 in Q4 2022 to 107,835 in Q1 2023, resulting in a 16% increase in the value of the shares. Similarly, Progressive Corp (PGR) saw an increase in shares held by Chicago Capital LLC from 466,785 in Q4 2022 to 484,875 in Q1 2023, resulting in a 14% increase in value.

Chicago Capital LLC's Top Losers

Edwards Lifesciences Corp (EW) saw a massive decrease in shares, with company holdings decreasing from 443,770 in Q4 2022 to 180,419 in Q1 2023, resulting in a 54% decrease in share value. Another company with decreasing shares was Ligand Pharmaceuticals Inc (LGND). The company's holdings decreased from 319,054 in Q4 2022 to 449,508 in Q1 2023, resulting in a 55% decrease in value.

Q4 Holders vs. Q1 Holders

Chicago Capital LLC's Q4 2022 vs. Q1 2023 holdings show a mix of gains and losses. Some of the most valuable companies in the world, like VISA, Apple, and Amazon (AMZN), had slight increases in shareholding value. Other companies, like Edwards Lifesciences Corp and Ligand Pharmaceuticals, saw a significant decrease in shareholding value. Furthermore, the firm's diversified portfolio showed some contradictions, as double-digit gains were seen in Salesforce Inc (CRM), Workday Inc (WDAY), and Zoetis Inc (ZTS), while losses occurred in Blackline Inc (BL), Lilly Eli & Co (LLY), and Pfizer Inc (PFE).

Investing can be a high-risk, high-reward endeavor. In conclusion, Chicago Capital LLC's Q4 2022 vs. Q1 2023 holdings report depicts how quickly market trends change and the importance of a diversified portfolio. It is crucial to analyze quarterly reports such as this to have quality investment decisions, considering the ever-changing world of investing.